We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-3.13%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$801B
AUM Growth
-$29.1B
Cap. Flow
+$16.3B
Cap. Flow %
2.03%
Top 10 Hldgs %
24.5%
Holding
5,100
New
137
Increased
3,082
Reduced
1,102
Closed
125

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.3B
2
MSFT icon
Microsoft
MSFT
+$1.3B
3
AMD icon
Advanced Micro Devices
AMD
+$925M
4
SPGI icon
S&P Global
SPGI
+$894M
5
TSLA icon
Tesla
TSLA
+$716M

Sector Composition

Rank Sector Weight
1 Technology 25.39%
2 Financials 13.32%
3 Healthcare 13.3%
4 Consumer Discretionary 11.44%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGRP
4626
DELISTED
SPAR Group
SGRP
$110K ﹤0.01%
85,088
SSAA
4627
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
$110K ﹤0.01%
+11,309
New +$110K
FENC icon
4628
Fennec Pharmaceuticals
FENC
$332M
$109K ﹤0.01%
19,507
-112
-0.6% -$564
NVCT icon
4629
Nuvectis Pharma
NVCT
$678M
$109K ﹤0.01%
+14,822
New +$103K
PTPI
4630
DELISTED
Petros Pharmaceuticals
PTPI
$109K ﹤0.01%
280
+45
+19% +$19K
TOMZ icon
4631
TOMI Environmental Solutions
TOMZ
$12.3M
$109K ﹤0.01%
40,238
+23,555
+141% +$76.3K
SUNE
4632
SUNation Energy
SUNE
$8.95M
0
ARMP icon
4633
Armata Pharmaceuticals
ARMP
$167M
$108K ﹤0.01%
22,221
+12,033
+118% +$61.6K
CNTX icon
4634
Context Therapeutics
CNTX
$55.1M
$108K ﹤0.01%
+49,912
New +$105K
MREO
4635
Mereo BioPharma
MREO
$54.7M
$108K ﹤0.01%
96,630
VRME icon
4636
VerifyMe
VRME
$9.38M
$108K ﹤0.01%
32,221
VECT
4637
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$108K ﹤0.01%
23,054
PFIN
4638
DELISTED
P&F Industries
PFIN
$108K ﹤0.01%
18,005
DAO
4639
Youdao
DAO
$2.03B
$107K ﹤0.01%
15,189
LKCO
4640
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$107K ﹤0.01%
876
ESSC
4641
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$107K ﹤0.01%
10,409
AILE
4642
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$107K ﹤0.01%
11,073
CREX icon
4643
Creative Realities
CREX
$41.1M
$106K ﹤0.01%
43,354
AONC
4644
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$106K ﹤0.01%
+10,892
New +$106K
HCII
4645
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$106K ﹤0.01%
+10,912
New +$106K
BXRX
4646
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$105K ﹤0.01%
1,490
+1,006
+208% +$186K
GANX icon
4647
Gain Therapeutics
GANX
$71.7M
$104K ﹤0.01%
25,628
+5,572
+28% +$23.3K
RDHL
4648
Redhill Biopharma
RDHL
$3.95M
$104K ﹤0.01%
42
+16
+62% +$37.9K
RBCN
4649
DELISTED
Rubicon Technology, Inc.
RBCN
$104K ﹤0.01%
11,566
CLRO icon
4650
ClearOne Inc
CLRO
$10.9M
$103K ﹤0.01%
7,538

Similar funds

Geode Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
  • Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
  • Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
  • Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
  • Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
  • Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
  • Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.